Kernal Biologics's multi-pronged approach to improving mRNA vaccine and therapeutic technologies includes the development of software that will use proprietary algorithms to help scientists create better designs for RNA-based drugs.
Company (Alive / Active)
700 Main Street
Massachusetts, United States
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)